Dempsey W L, Mansfield J M
J Immunol. 1983 Jun;130(6):2896-8.
The ability of mice infected with African trypanosomes to produce antibodies to the surface antigen of the infecting trypanosome variant antigenic type upon primary and secondary exposure was examined. C57BL/10SnJ mice were infected initially with Trypanosoma rhodesiense clone LouTat 1.0. Surface antigen-specific antibody titers (IgM and IgG) to the infecting variant were measured throughout the course of infection; when the titers were sufficiently low, mice were reinfected with LouTat 1.0 trypanosomes and the antibody response was measured. Results demonstrate that mice in the early stage of infection exhibited transient suppression of antibody responses to LouTat 1.0 upon reexposure. In contrast, mice in the terminal phase of the disease were completely suppressed in their ability to mount a humoral response to LouTat 1.0. Trypanocidal chemotherapy of mice restored immunoresponsiveness in that treated mice responded with both IgM and IgG surface antigen-specific antibody to LouTat 1.0. The resulting antibody response, however, was more indicative of a primary humoral response to the parasites rather than a true secondary immune response.
研究了感染非洲锥虫的小鼠在初次和再次接触感染性锥虫变体抗原型表面抗原时产生抗体的能力。最初用罗德西亚锥虫克隆LouTat 1.0感染C57BL/10SnJ小鼠。在整个感染过程中测量针对感染性变体的表面抗原特异性抗体滴度(IgM和IgG);当滴度足够低时,用LouTat 1.0锥虫再次感染小鼠并测量抗体反应。结果表明,感染早期的小鼠再次接触时对LouTat 1.0的抗体反应表现出短暂抑制。相反,疾病终末期的小鼠对LouTat 1.0产生体液反应的能力完全受到抑制。对小鼠进行杀锥虫化疗可恢复免疫反应性,即治疗后的小鼠对LouTat 1.0产生IgM和IgG表面抗原特异性抗体反应。然而,所产生的抗体反应更表明是对寄生虫的初次体液反应,而不是真正的二次免疫反应。